Patients reported lower rates of nausea and vomiting, and no new safety concerns were identified
How to verify your specific plan
By the first quarter of 2026, tirzepatide had become the most frequently prescribed agent at roughly 4,700 prescriptions per 100,000 patients, and semaglutide had grown to around 3,900 per 100,000
Brand-name FDA-approved options are listed at higher monthly price points
Each patients medication regimen should be individualized to his or her needs, and the cost of these therapies should be considered
Qsymia combines phentermine and topiramate (a seizure medication used off-label for appetite suppression)